BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026
BAROPHARM Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 2,342 | 3,743 | 3,538 | 436.81 |
Short-Term Investments | 22,358 | 11,900 | 23,900 | 12,100 |
Cash & Short-Term Investments | 24,701 | 15,643 | 27,438 | 12,537 |
Cash Growth | - | -42.99% | 118.86% | - |
Accounts Receivable | 10,596 | 9,285 | 6,454 | 610.52 |
Other Receivables | 6,413 | 5,656 | 5,901 | 3,281 |
Receivables | 17,009 | 14,941 | 12,354 | 3,892 |
Inventory | 20,683 | 19,354 | 12,488 | 1,521 |
Prepaid Expenses | - | - | - | 18.24 |
Other Current Assets | 4,059 | 5,840 | 3,969 | 7,514 |
Total Current Assets | 66,452 | 55,779 | 56,250 | 25,482 |
Property, Plant & Equipment | 21,747 | 21,406 | 1,512 | 1,524 |
Long-Term Investments | 15 | 12.3 | 8.7 | 5.1 |
Goodwill | 2,487 | 2,276 | 1,589 | 1,589 |
Other Intangible Assets | 756.83 | 295.43 | 93.66 | 122.11 |
Other Long-Term Assets | 786.14 | 1,165 | 864.58 | 707.47 |
Total Assets | 92,244 | 80,933 | 60,318 | 29,430 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 18,710 | 15,655 | 12,376 | 778.87 |
Accrued Expenses | 1,231 | 4,209 | 3,548 | 3,697 |
Short-Term Debt | 14,575 | 14,700 | 200 | 200 |
Current Portion of Leases | 410.66 | 766.34 | 450.07 | 337.71 |
Current Income Taxes Payable | 78.6 | - | 77.82 | - |
Current Unearned Revenue | 24.16 | 12.41 | - | - |
Other Current Liabilities | 18,000 | 13,429 | 54,437 | 27,809 |
Total Current Liabilities | 53,030 | 48,770 | 71,089 | 32,823 |
Long-Term Debt | - | - | - | 3,006 |
Long-Term Leases | 570.62 | 651.5 | 499.15 | 501.99 |
Long-Term Deferred Tax Liabilities | 46.59 | 50.39 | - | - |
Other Long-Term Liabilities | 859.52 | 787.43 | 4,093 | 2,976 |
Total Liabilities | 54,507 | 50,260 | 75,680 | 39,307 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 5,057 | 4,697 | 3,167 | 444.98 |
Additional Paid-In Capital | 69,626 | 63,541 | 759.49 | 532.17 |
Retained Earnings | -38,839 | -42,848 | -33,169 | -15,647 |
Comprehensive Income & Other | 1,893 | 5,284 | 4,368 | 3,195 |
Total Common Equity | 37,738 | 30,673 | -24,875 | -11,475 |
Shareholders' Equity | 37,738 | 30,673 | -15,363 | -9,877 |
Total Liabilities & Equity | 92,244 | 80,933 | 60,318 | 29,430 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 15,556 | 16,118 | 1,149 | 4,046 |
Net Cash (Debt) | 9,144 | -474.44 | 26,289 | 8,491 |
Net Cash Growth | - | - | 209.62% | - |
Net Cash Per Share | 969.75 | -71.63 | 4207.89 | 1363.24 |
Filing Date Shares Outstanding | 10.14 | 9.39 | 6.33 | 6.23 |
Total Common Shares Outstanding | 10.14 | 9.39 | 6.33 | 6.23 |
Working Capital | 13,422 | 7,008 | -14,839 | -7,341 |
Book Value Per Share | 3723.48 | 3265.32 | -3927.22 | -1842.34 |
Tangible Book Value | 34,494 | 28,102 | -26,557 | -13,186 |
Tangible Book Value Per Share | 3403.40 | 2991.58 | -4192.90 | -2117.10 |
Land | 18,727 | 18,727 | - | - |
Buildings | 1,488 | 1,479 | - | - |
Machinery | 2,217 | 1,873 | 800.38 | 720.51 |
Construction In Progress | 23.5 | 22.31 | - | - |